Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Net Margin (2022 - 2025)

TriSalus Life Sciences (TLSI) has 4 years of Net Margin data on record, last reported at 73.86% in Q4 2025.

  • For Q4 2025, Net Margin rose 5798.0% year-over-year to 73.86%; the TTM value through Dec 2025 reached 154.35%, down 4143.0%, while the annual FY2025 figure was 154.35%, 4143.0% down from the prior year.
  • Net Margin reached 73.86% in Q4 2025 per TLSI's latest filing, up from 344.53% in the prior quarter.
  • Across five years, Net Margin topped out at 5.61% in Q2 2023 and bottomed at 1696.28% in Q4 2022.
  • Average Net Margin over 4 years is 310.92%, with a median of 120.94% recorded in 2025.
  • Peak YoY movement for Net Margin: soared 78327bps in 2023, then tumbled -30096bps in 2025.
  • A 4-year view of Net Margin shows it stood at 1696.28% in 2022, then surged by 46bps to 913.01% in 2023, then surged by 86bps to 131.84% in 2024, then surged by 44bps to 73.86% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 73.86% in Q4 2025, 344.53% in Q3 2025, and 80.28% in Q2 2025.